Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Vascular degeneration and restoration Angiogenesis ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by